SOAT1 and rheumatoid arthritis: In rheumatoid arthritis, tofacitinib significantly increased oxidative phosphorylation, ATP production, and the maximal respiratory capacity and the respiratory reserve in primary synovial fibroblasts, suggesting JAK/STAT signaling as a mediator of the complex interplay between inflammation and cellular metabolism (McGarry et al., 2018).